Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines.
Machover D, Diaz-Rubio E, de Gramont A, Schilf A, Gastiaburu JJ, Brienza S, Itzhaki M, Metzger G, N'Daw D, Vignoud J, Abad A, Francois E, Gamelin E, Marty M, Sastre J, Seitz JF, Ychou M. Machover D, et al. Among authors: vignoud j. Ann Oncol. 1996 Jan;7(1):95-8. doi: 10.1093/oxfordjournals.annonc.a010489. Ann Oncol. 1996. PMID: 9081400 Free article. Clinical Trial.
Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas.
Beauvillain C, Mahé M, Bourdin S, Peuvrel P, Bergerot P, Rivière A, Vignoud J, Deraucourt D, Wesoluch M. Beauvillain C, et al. Among authors: vignoud j. Laryngoscope. 1997 May;107(5):648-53. doi: 10.1097/00005537-199705000-00017. Laryngoscope. 1997. PMID: 9149168 Clinical Trial.
Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.
Culine S, Iborra F, Mottet N, Avancès C, de Graeve B, Volpé P, Vignoud J, Bringer JP, Marroncle M, Le Pellec L, Ayuso D, Jansen E, Faix A, Rebillard X. Culine S, et al. Among authors: vignoud j. Am J Clin Oncol. 2006 Apr;29(2):148-52. doi: 10.1097/01.coc.0000203753.74851.d5. Am J Clin Oncol. 2006. PMID: 16601433 Clinical Trial.
[Esophageal cancer: did combined treatments improve prognosis?].
Ganem G, Raoul Y, Goudier MJ, Dubray B, Colin P, Extra JM, Hennequin C, Michel-Langlet P, Vignoud J, Bardet E. Ganem G, et al. Among authors: vignoud j. Bull Cancer. 1992;79(8):735-50. Bull Cancer. 1992. PMID: 1467597 Review. French.
Immunotherapy of gastrointestinal cancer with monoclonal antibodies.
Douillard JY, Le Mevel B, Curtet C, Vignoud J, Chatal JF, Koprowski H. Douillard JY, et al. Among authors: vignoud j. Med Oncol Tumor Pharmacother. 1986;3(3-4):141-6. doi: 10.1007/BF02934989. Med Oncol Tumor Pharmacother. 1986. PMID: 3468318
14 results